bioRxiv

bioRxiv is a free preprint archive for life sciences researchers who want to share data-backed findings before journal submission. It suits authors seeking early visibility and readers looking for emerging work, provided they treat posted manuscripts as unreviewed research.

Overview

Founded in 2013 and operated by nonprofit openRxiv, bioRxiv accepts research preprints across life-science subjects including genetics, neuroscience, ecology and bioinformatics. Its broad scope and free access make it useful for circulating findings across biological fields without requiring readers to pay for access.

Posting does not amount to scientific endorsement: articles appear without peer review, editing or typesetting. Screening checks completeness and scope, runs automated analyses for potential plagiarism or prior online posting, and asks volunteer bioRxiv Affiliates to assess biological relevance and possible public harm. This is a meaningful initial filter, but not a substitute for journal review. Screening typically takes 24–48 hours and may take longer over weekends, holidays or when further discussion is needed.

Key features

Authors can revise preprints until formal journal acceptance, but cannot remove a posted article. That permanence gives early work a lasting public record; it also means authors should be prepared for the submitted work to remain accessible even if they later change direction.

Readers can leave public comments, moderated to maintain normal professional discourse. This creates a route for discussion, though it does not turn comments into formal peer review. The B2J service can send manuscript files and metadata directly to participating journals or peer-review services, reducing repeated submission work when a destination supports the service.

Access extends beyond the website: bioRxiv offers article metadata through RSS feeds and APIs, plus bulk full text through an Amazon S3 resource for text and data mining. The API returns article metadata in JSON, XML or HTML and paginates multi-paper results. Authors retain copyright and choose from reuse options including CC BY, CC BY-NC, CC BY-ND, CC BY-NC-ND, CC0 or no reuse.

The archive does not accept narrative reviews, commentaries, opinion pieces or step-by-step protocols as article types; research articles must contain data. That boundary keeps its purpose focused on research findings, but rules out several common forms of scholarly communication.

Pricing

The Free plan costs nothing, billed Free. It includes the online archive and distribution service, with manuscript submissions free of charge. There is no free trial because the service is free. For authors and readers seeking life-sciences preprints, there is no paid tier to unlock access or submission; the trade-off is that bioRxiv is a preprint service rather than a peer-reviewed publication route.

Platforms

bioRxiv is available on the web and through an API. The API's structured metadata and pagination suit programmatic discovery, while web access serves readers browsing and reading articles. The entry also identifies full-text access and advanced search.

Who it's for

Choose bioRxiv if you are a life-science researcher with a data-backed manuscript and want to disseminate it before journal submission, invite public feedback or use B2J to transfer it to a participating journal or review service. It also fits readers who want free access to emerging research or developers and analysts working with article metadata and bulk text.

It is a poor fit for authors seeking peer review before publication, a removable posting, or a venue for a commentary, narrative review, opinion piece or step-by-step protocol. Readers should not treat a preprint's presence as evidence that its scientific claims have been validated.

Pros and cons

Pros

• Free submissions and reading: authors can distribute eligible manuscripts and readers can access articles without a subscription charge.
• Useful routes for follow-up: public comments, revisions before formal journal acceptance and B2J transfer support feedback and onward submission.
• Open machine access: APIs, RSS feeds and bulk full text support discovery and text and data mining.
• Author-selected reuse: a range of licensing choices, including CC0 and no reuse, lets authors set terms for their work.

Cons

• No peer review before posting: readers must assess findings without the validation of journal review.
• Posting is permanent: authors cannot remove an article after it is posted.
• Narrow submission formats: manuscripts must be data-containing research articles, excluding several other scholarly article types.
• Screening is not instantaneous: the typical 24–48-hour process can take longer when calendars or further discussion intervene.

Alternatives

For a broader directory of discovery tools, browse Academic Research Databases.

• arXiv is another free open-access archive with no-cost submissions; choose it when your work belongs in its archive rather than bioRxiv's life-sciences focus.
• Europe PMC offers free access to life-sciences literature and related tools; choose it for literature access beyond bioRxiv preprints.
• AGRICOLA provides a free public catalog, with individual article full text depending on linked sources; choose it for catalog discovery rather than a preprint archive.
• JSTOR has a free read-only plan for open content and public-domain articles, with limited free reading of select items; choose it when that reading collection better suits your needs.
• Academia.edu offers free paper reading, bookmarking, downloads, search, academic follows, uploads and basic analytics; choose it for those researcher-networking and account tools.
• CORE offers API access subject to rate limits; choose it if its API access model is a better fit for your discovery workflow.
• MAXQDA is a paid research application for macOS and Windows, with a free trial; choose it when you need research software rather than a preprint archive.
• EconLit offers courtesy access to AEA members but no full-text links on that plan; choose it for economics-focused bibliographic discovery.

Verdict

bioRxiv is the right choice for life-sciences researchers who want free, early distribution of data-backed findings, especially when public feedback or transfer to a participating journal matters. Its open access and machine-readable routes are substantial strengths. Look elsewhere if you need peer-reviewed publication before work appears, want the ability to retract a posting, or have a manuscript type the archive does not accept.